CNO Financial Group Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
CNO Financial Group
Download Your Competitive Advantage
CNO Financial Group’s BCG Matrix preview highlights its core life insurance and retirement products—showing potential Stars in growing annuity segments, Cash Cows from legacy life portfolios, and Question Marks where digital distribution is nascent. Dive deeper into this company’s BCG Matrix and gain a clear view of where its products stand—Stars, Cash Cows, Dogs, or Question Marks. Purchase the full version for a complete breakdown and strategic insights you can act on.
Stars
Optavise Worksite Benefits
Optavise Worksite Benefits, part of CNO Financial Group, is a high-growth leader combining healthcare advocacy, benefits enrollment, and voluntary insurance products, driving a 28% CAGR in voluntary sales from 2020–2024 and adding 1.2 million members by FY2024.
As employers shift to personalized benefits, Optavise’s service-driven model captured roughly 18% of CNO’s employer-channel revenue in 2024 and increased employer retention to 91%.
To sustain growth in the expanding voluntary benefits market—projected at $75 billion U.S. by 2026—Optavise needs continued investment: roughly $45–60 million over 2025–2026 in cloud platforms and 150–200 sales hires to keep its competitive edge.
Direct-to-Consumer Medicare Supplement
Direct-to-Consumer Medicare Supplement sits as a Star: CNO Financial Group (CNO) has grown digital and telephonic sales, capturing seniors who buy online—Medicare Supplement online purchases rose ~18% CAGR 2019–2024, per industry surveys. CNO’s 2024 marketing spend jumped to ~$220m, led by Colonial Penn, to sustain share and fund customer acquisition. High CAC but strong unit economics keep it a growth market leader.
Bankers Life Hybrid Long-Term Care
The market for hybrid life/long-term care (LTC) products grew ~12% in 2024 as middle-income buyers sought aging-in-place solutions; industry premiums hit $4.3B in 2024 per LIMRA.
CNO Financial Group’s Bankers Life Hybrid LTC is a BCG Stars candidate—strong growth and significant market share—driven by its 6,000+ career agents who educate clients on product complexity.
These hybrids require higher reserves under NAIC model rules, tying up capital; still, CNO projects protection-segment revenue growth of ~8–10% annually through 2026, making hybrids central to its strategy.
Wealth Management and Advisory Services
Wealth Management and Advisory is a rising Star for CNO Financial Group (CNO) as it moves from insurance-only to holistic financial services, helping capture more retirement-planning share amid the Silver Tsunami—US 65+ population projected at 71.6 million in 2025 (22% of population).
Demand centers on asset decumulation and wealth transfer; advisory AUM reached about $1.2bn in 2024 within CNO’s platform, up ~18% YoY, showing strong growth.
To sustain momentum CNO must keep investing in recruiting and training dually licensed advisors (insurance+RIA/CFP), aiming to grow advisor headcount by ~25% through 2026 to limit capacity constraints.
- Target market: 71.6M Americans 65+ in 2025
- AUM: ~$1.2bn (2024), +18% YoY
- Priority: hire/train dually licensed advisors
- Goal: +25% advisor headcount by 2026
Washington National Supplemental Health
Washington National, CNO Financial Group’s supplemental health star, targets niche critical-illness and accident policies as out-of-pocket U.S. medical spending rose to $597 billion in 2023, boosting demand for such covers.
It keeps strong rural and middle-market distribution via ~10,000 independent agents, sustaining retention and low acquisition costs compared with direct channels.
Rising supplemental-health awareness—search interest up ~35% YoY in 2024—makes Washington National a primary engine for new policyholder growth within CNO.
- Focus: critical-illness and accident insurance
- Market tailwind: $597B out-of-pocket spending (2023)
- Distribution: ~10,000 independent agents
- Demand signal: +35% search interest YoY (2024)
CNO Growth Leaders: Optavise, Medicare, Hybrid LTC, Wealth & Washington National
CNO’s Stars: Optavise (28% CAGR voluntary sales 2020–24; +1.2M members FY2024), Direct-to-Consumer Medicare Supplement (marketing ~$220M 2024; online Medicare buy +18% CAGR 2019–24), Bankers Life Hybrid LTC (6,000+ agents; protection revenue +8–10% p.a. to 2026), Wealth Advisory (AUM ~$1.2B 2024; +18% YoY), Washington National (≈10,000 agents; supplemental demand up).
| Unit | Key metric |
|---|---|
| Optavise | 28% CAGR; +1.2M members |
| Medicare | $220M marketing; +18% online CAGR |
| Hybrid LTC | 6,000+ agents; +8–10% rev p.a. |
| Wealth | $1.2B AUM; +18% YoY |
| Wash. Natl | ~10,000 agents; rising demand |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix breakdown of CNO Financial’s units with strategic actions for Stars, Cash Cows, Question Marks, and Dogs.
Customizable Excel Spreadsheet
One-page CNO Financial Group BCG Matrix placing each business unit in a quadrant for quick strategic clarity
Cash Cows
Bankers Life Legacy Life Insurance
Bankers Life Legacy Life Insurance, within CNO Financial Group, is a mature cash cow: its whole-life and term portfolios dominate the U.S. middle-income segment and produced roughly $1.1 billion in premiums in 2024, with persistency >80% and acquisition costs under 15% of first-year premium.
These older blocks yield steady positive operating cash flow—about $320 million in 2024—which funds CNO’s dividends and enabled $150 million in share repurchases in 2024.
Colonial Penn Guaranteed Acceptance Life
Colonial Penn Guaranteed Acceptance Life, a household name in final expense insurance, delivers steady premium volumes—CNO reported individual life premiums of $1.9B in 2024, with Colonial Penn a major contributor—providing predictable mortality cash flow and low lapse volatility.
Growth is mature and steady, not explosive, yet high policy counts generate reliable liquidity; Colonial Penn functions as CNO’s primary cash source to fund 2024–25 growth initiatives and acquisitions.
Fixed Indexed Annuities
CNO Financial Group holds roughly a mid-to-high single-digit share of the US fixed indexed annuity (FIA) market, serving risk-averse retirees with principal-protected options; FIAs drove about $400–500 million in annualized premium for CNO in 2024.
As a mature category, FIAs show retention rates north of 85% and sell mainly through CNO’s career agent force, reducing acquisition spend and smoothing cashflows.
Healthy product margins—estimated 10–15% net in 2024—generate free cash to cover corporate debt (about $1.2 billion total debt at year-end 2024) and fund IT and distribution upgrades.
Medicare Supplement Traditional Block
The Medicare Supplement Traditional Block, sold via CNO Financial Group’s legacy agent network, delivers steady annual premiums of roughly $800–900 million and low lapse rates near 6% (2024), making it a classic Cash Cow in the BCG matrix.
Because the offline market is mature, CNO prioritizes cost efficiency and retention—targeting 2–3% annual expense reductions and retention improvement programs—instead of growth campaigns.
This predictable cash flow funds higher-risk growth initiatives and cushions earnings volatility from newer product lines and investments.
- Annual premiums ≈ $800–900M
- Lapse rate ≈ 6% (2024)
- Targeted expense cuts 2–3% p.a.
- Funds growth and volatility buffer
Washington National Worksite Life
Washington National Worksite, part of CNO Financial Group, generates stable recurring premiums—about $420m annualized in 2024—from payroll-deducted term and whole-life products, giving persistency rates above 85% and low acquisition cost per policy (~$35), which yields steady underwriting margins used to fund capital-hungry growth initiatives like Optavise.
These low-overhead cash flows help CNO cover fixed costs and reallocate roughly $60–80m annually (2024 estimate) toward distribution and tech investment for Star products while keeping combined ratio and expense load favorable.
- 2024 premium run-rate ≈ $420m
- Persistency >85%
- Acquisition cost ≈ $35/policy
- Annual reallocation to Stars ≈ $60–80m
CNO’s Cash Cows: $320M Ops, $1.9B Life, FIAs $400–500M, Med Supp $800–900M
Bankers Life, Colonial Penn, FIAs, Medicare Supplement, and Washington National form CNO’s cash cows, generating ~ $320M operating cash flow, ~$1.9B individual life premiums, $400–500M FIA sales, $800–900M Medicare supplement premiums, and ~$420M worksite premiums in 2024, funding dividends, $150M buybacks, debt service (~$1.2B) and $60–80M annual reinvestment.
| Product | 2024 |
|---|---|
| Op. cash flow | $320M |
| Life premiums | $1.9B |
| FIAs | $400–500M |
| Med Supp | $800–900M |
| Worksite | $420M |
What You’re Viewing Is Included
CNO Financial Group BCG Matrix
The file you're previewing is the exact CNO Financial Group BCG Matrix report you'll receive after purchase—no watermarks, no demo content—just a fully formatted, analysis-ready document crafted for strategic clarity. This preview matches the downloadable file verbatim and is ready for editing, printing, or presentation to stakeholders. Delivered immediately upon purchase, the report combines market-backed insights and clean design so you can plug it into planning or client deliverables without modification.
Dogs
Legacy Long-Term Care (Closed Block)
Legacy Long-Term Care (Closed Block) contains older stand-alone LTC policies CNO stopped marketing, with reported statutory reserves of about $1.2 billion and adverse loss ratios above 120% in 2024, driving repeated premium rate increases.
These policies hold negligible market share and produced a negative operating impact in 2024, lowering CNO’s consolidated ROE by roughly 1.5 percentage points.
CNO manages the block for capital preservation—running off liabilities, restricting new sales, and using reinsurance and reserve strengthening rather than pursuing growth.
Single Premium Whole Life
Single Premium Whole Life at CNO Financial Group faces headwinds: in 2025 rising rate volatility pushed demand down 28% year-over-year industry-wide, and CNO reports the product as under 2% of individual life sales, marking it a small niche.
These policies are low-growth, low-share BCG dogs—sales volumes and net written premium fell while admin costs per policy run ~15% higher than term/UL products, so marginal returns lag modern accumulation vehicles.
Traditional Fixed Rate Annuities
Standard fixed-rate annuities have slid in appeal for middle-income buyers, who favored indexed and variable options that delivered 6–8% average returns in 2024 versus typical fixed rates near 3%; CNO Financial Group (ticker: CNO) holds only a single-digit share in this basic segment.
These products trade as commodities with industry net margins under 5% and rising lapse sensitivity, so CNO sees limited revenue lift and no clear route to market leadership.
Legacy Independent Brokerage Life
Legacy independent-brokerage life for CNO Financial Group shows low growth and weak brand loyalty; industry data in 2024 reported lapse rates near 12–15% annually for legacy term and whole life sold through third-party brokers, versus ~6–8% for career-agent channels.
CNO has actively shifted distribution to proprietary career agents since 2021, reducing reliance on independent channels; premiums from independent agents fell by roughly 30% from 2021–2024, leaving this segment misaligned with CNO’s integrated-advice strategy.
- High lapse rates: ~12–15% (2024)
- Career-agent lapse: ~6–8% (2024)
- Independent-channel premium decline: ~30% (2021–2024)
- Segment: low growth, strategic dog
Small-Group Major Medical Tail
Small-Group Major Medical Tail: CNO’s legacy major medical lines are a Dog—regulatory costs and claims volatility plus subscale operations versus giants like UnitedHealth and Anthem; 2024 estimated combined ratio >110% and less than 5% of CNO’s premium base make it uneconomic.
It lacks sustainable advantage and is slated for runoff or divestiture to free capital; selling could reallocate ~$50–100m of statutory capital based on 2024 reserves and RBC (risk-based capital) metrics.
- High regulatory burden — drives loss ratio above peers
- Low scale — under 5% premium share at CNO (2024)
- Combined ratio >110% (2024 est.)
- Candidate for runoff/divestiture to free $50–100m capital
CNO to Runoff/Divest Loss-Making Legacy Lines to Free ~$1.2B Capital
CNO’s Dogs: legacy LTC closed block (reserves ~$1.2B; loss ratio >120% in 2024), single-premium whole life (<2% sales; demand -28% YoY in 2025), standard fixed annuities (single-digit share; industry margins <5% in 2024), and legacy small-group major medical (combined ratio >110%; <5% premium share). These are runoff/divestiture candidates to free capital.
| Segment | Key 2024–25 Metrics |
|---|---|
| Legacy LTC | Reserves $1.2B; LR>120% |
| SPWL | <2% sales; demand -28% (2025) |
| Fixed annuities | Share: single-digit; margins <5% |
| Small-group MM | CR>110%; <5% premium share |
Question Marks
Direct-to-Consumer Wealth Management
CNO Financial Group is piloting direct-to-consumer digital advice platforms targeting younger, tech-native middle-income customers, but holds a single-digit market share in robo-advice vs. incumbents like Vanguard Personal Advisor Services and Betterment; global robo-advice AUM hit about $2.3 trillion in 2025.
Converting Colonial Penn’s customer base will need heavy tech and distribution spend; estimated platform build and marketing could exceed $50–100 million over 3 years to reach scale and meaningful AUM inflows.
Short-Term Care Insurance
Short-term care insurance offers lower-cost alternatives to long-term care; about 35% of consumers cite cost as primary barrier to LTC in 2024 surveys, so CNO Financial Group (CNO: NYSE) exploring this space targets a large underserved segment.
The category is nascent: industry premiums for short-term care grew ~12% in 2023 but carriers report mixed loss ratios; CNO must invest in heavy marketing and agent training to test scalability.
If CNO captures >5% market share within 3–5 years and achieves loss ratios near 65%, the line could transition from Question Mark to Star; otherwise profitability remains unproven.
Integrated Health-Wealth Platforms
CNO Financial Group is piloting integrated health-wealth portals—so-called super-apps—that bundle insurance management with retirement planning and investment tools; adoption remains nascent with fewer than 100,000 users reported in 2025 pilots versus industry leaders reaching millions.
The shift to digital-first models is underway across insurers: 72% of US retirees used at least one digital financial service in 2024, but CNO’s middle-market senior base skews toward lower digital engagement, slowing pickup.
Success hinges on conversion of middle-market seniors to a full digital ecosystem; if monthly active user growth stays below 5% and retention under 60%, the initiative risks remaining a Question Mark in CNO’s BCG matrix.
Worksite Behavioral Health Add-ons
Worksite Behavioral Health Add-ons via Optavise target a US employer mental health market growing ~9% CAGR to $45B by 2027; CNO is a small entrant versus specialty firms, so this sits as a Question Mark in the BCG matrix.
If uptake follows industry benchmarks (10–20% penetration in 3 years), these add-ons could lift worksite segment revenue by 15–30%, but current SG&A and product development push net cash flow negative.
2024 figures: Optavise pilot costs ~ $12M, expected 2025 incremental revenue $3–7M; ROI breakeven likely 4–6 years assuming 15% annual subscription growth and 70% retention.
- High market growth (~9% CAGR to $45B by 2027)
- Small market share vs specialists — Question Mark
- Pilot spend $12M (2024) vs 2025 revenue $3–7M
- Potential +15–30% worksite revenue if 10–20% penetration
- Cash-negative now; breakeven 4–6 years at 15% growth
Registered Index-Linked Annuities (RILA)
RILAs (registered index-linked annuities) are among the fastest-growing annuity segments, with industry sales rising ~18% in 2024 to about $45B; CNO Financial is expanding into RILAs but holds a low market share versus larger insurers with established offerings.
High upfront commissions (often 3–6% of premium) and product development costs make RILAs speculative for CNO, yet margins and fee income could be lucrative if distribution scales; breakeven likely requires multi-year volume growth.
- CNO strategy: increase RILA distribution and partnerships
- Market size: ~45B sales in 2024, +18% vs 2023
- Costs: commissions 3–6% + high dev/hedging expense
- Risk/reward: low share now, high upside if scale achieved
CNO’s Strategic Bets: Robo‑advice, Short‑Term Care, Optavise Pilot & RILA Growth
CNO’s Question Marks: digital robo-advice (single-digit share; global robo AUM ~$2.3T in 2025), short-term care (market growth +12% in 2023; conversion cost $50–100M over 3 years), Optavise worksite mental-health pilot ($12M 2024 cost; $3–7M 2025 revenue; breakeven 4–6 yrs), RILA push (industry sales ~$45B in 2024, +18%).
| Initiative | Key metric | 2024–25 data |
|---|---|---|
| Robo-advice | Global AUM / share | $2.3T (2025) / CNO single-digit |
| Short-term care | Build & marketing | $50–100M (3 yrs) |
| Optavise | Pilot cost / 2025 rev | $12M / $3–7M |
| RILAs | Industry sales | $45B (2024), +18% |